FisherRSImitators of Epilepsy. New York: Demos; 1994.
2.
CockerellOCShorvonSDThe economic cost of epilepsy. In: ShorvonSDreifussFFishDThomasD (eds). The Treatment of Epilepsy. London: Black-well Science; 1996: 114–119.
3.
PffeferJMThe aetiology of the hyperventilation syndrome: a review of the literature. Psychother Psychosom1978; 30: 47–55.
4.
RileyTLRoyARPseudoseizures. Baltimore/London: Williams and Wilkins; 1982.
5.
LelliottPTFenwickP.Cerebral pathology in pseudoseizures. Acta Neurol Scand1991; 83: 129–132.
6.
GowersWREpilepsy and Other Chronic Convulsive Diseases. London: Churchill; 1881.
7.
ReynoldsEHElwesRDCShorvonS.Why does epilepsy become intractable?Lancet1983; 2: 952–954.
8.
MurrayM. Unpublished data, cited by Privitera M in the Parke-Davis website, 1997.
9.
BegleyCEAnnegersJFLairsonDCost of epilepsy in the United States: a model based on incidence and prognosis. Epilepsia1994; 35: 1230–1243.
10.
DaySCCookEFFunkensteinHGoldmanL.Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med1982; 73: 15–23.
11.
CockerellOCHartYMSanderJWASShorvonSDThe cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies. Epilepsy Res1994; 18: 249–260.
12.
GrossM.Pseudoepilepsy: The Clinical Aspects of False Seizures. Lexington MA: Lexington Books; 1983.
American Electroencephalographic Society, Guidelines: Long-Term Monitoring For Epilepsy. Bloomfield, CT: American Electroencephalographic Society; 1991.
16.
LesserRPPsychogenic seizures. In: PedleyTAMeldrumBS (eds). Recent Advances in Epilepsy 2. London, New York: Churchill Livingstone; 1985; 273–296.